1. Home
  2. Labeler Index
  3. Novartis Pharmaceuticals Corporation
  4. 0078-0953
  5. Label Information: Tobradex

FDA Label for Tobradex

View Indications, Usage & Precautions

Table of Contents

    1. PRINCIPAL DISPLAY PANEL

Tobradex Product Label

The following document was submitted to the FDA by the labeler of this product Novartis Pharmaceuticals Corporation. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Principal Display Panel



NDC 0078-0953-25

TobraDex®

(tobramycin and
dexamethasone
ophthalmic
suspension, USP)
0.3%/0.1%

FOR TOPICAL OPHTHALMIC USE

5 mL

Sterile

NOVARTIS

PRINCIPAL DISPLAY PANEL 0078-0953-25 TobraDex® (tobramycin and dexamethasone ophthalmic suspension, USP) 0.3%/0.1% FOR TOPICAL OPHTHALMIC USE 5 mL Sterile NOVARTIS - carton

PRINCIPAL DISPLAY PANEL 0078-0953-25 TobraDex® (tobramycin and dexamethasone ophthalmic suspension, USP) 0.3%/0.1% FOR TOPICAL OPHTHALMIC USE 5 mL Sterile NOVARTIS - carton


* Please review the disclaimer below.